US20110008250A1 - Treatment of Autoimmune Diseases - Google Patents

Treatment of Autoimmune Diseases Download PDF

Info

Publication number
US20110008250A1
US20110008250A1 US12/886,205 US88620510A US2011008250A1 US 20110008250 A1 US20110008250 A1 US 20110008250A1 US 88620510 A US88620510 A US 88620510A US 2011008250 A1 US2011008250 A1 US 2011008250A1
Authority
US
United States
Prior art keywords
antibody
method
antagonist
antibodies
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/886,205
Inventor
John G. Curd
Lori A. Kunkel
Antonio J. Grillo-Lopez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genentech Inc
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US13301899P priority Critical
Priority to US13962199P priority
Priority to US09/564,288 priority patent/US7820161B1/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26830960&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=US20110008250(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority to US12/886,205 priority patent/US20110008250A1/en
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of US20110008250A1 publication Critical patent/US20110008250A1/en
Application status is Abandoned legal-status Critical

Links